https://orcid.org/0000-0002-5721-7855
References
- Lang H-C, Chen H-W, Chiou T-J, et al. The real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu-positive early breast cancer in Taiwan. J Med Econ. 2016;19(10):923–927.
- Berhili S, Kadiri S, Bouziane A, et al. Associated factors with psychological distress in Moroccan breast cancer patients: a cross-sectional study. Breast. 2017;31:26–33.
- Zhang Z, Zhang X, Wei L, et al. Questionnaire to assess quality of life in patients with breast cancer – validation of the Chinese version of the EORTC QLQ-BR 53. Breast. 2017;32:87–92.
- Leung HWC, Chan ALF, Muo C-H, et al. Cost-effectiveness of pertuzumab combined with trastuzumab and docetaxel as a first-line treatment for HER-2 positive metastatic breast cancer. Expert Rev Pharmacoecon Outcomes Res. 2018;18(2):207–213.
- Hsu S, Chen C, Yu J, et al. The effect of using multimedia education in women’s breast cancer screening health education program. Int J Environ Res Public Health. 2019. DOI:https://doi.org/10.20944/preprints201905.0055.v1
- Kim M, Kim H, Choi H, et al. Age-standardized breast cancer detection rates of breast cancer screening program by age group in Korea; comparison with age-standardized incidence rates from the Korea Central Cancer Registry. Healthcare (Basel). 2020;8(2):132.
- Simoens S, van Harten W, Lopes G, et al. What happens when the cost of cancer care becomes unsustainable. Eur Oncol Haematol. 2017;13(02):108–113.
- Sun L, Legood R, dos-Santos-Silva I, et al. Global treatment costs of breast cancer by stage: a systematic review. PLOS One. 2018;13(11):e0207993.
- Chongsuvivatwong V, Phua KH, Yap MT, et al. Health and health-care systems in southeast Asia: diversity and transitions. Lancet. 2011;377(9763):429–437.
- Tangcharoensathien V, Patcharanarumol W, Ir P, et al. Health-financing reforms in southeast Asia: challenges in achieving universal coverage. Lancet. 2011;377(9768):863–873.
- van Doorslaer E, O’Donnel O, Rannan-Eliya RP, et al. Paying out-of-pocket for health care in Asia: catastrophic and poverty impact. EQUITAP Project: Working Paper # 2. May 2005. (Free FullText Downloaded from ResearchGate)
- Lee TJ. Paying out-of-pocket for health care in Korea: change in catastrophic and poverty impact over a decade. 2011. Available from: http://ebookbrowse.com/rp254-takemi-journal1-lee-pdf-d57080924
- Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist. 2013;18(4):381–390.
- The World Bank, World Health Organization Global Health Expenditure database [Internet] [cited 2021 Jan 30]. Available from: https://data.worldbank.org/indicator/SH.XPD.OOPC.PC.CD
- Barry AM, Casselman B. 33 Million Americans still don’t have health insurance. Here’s who they are. Report on public health, food and culture for FiveThirtyEight. [updated 2015 Sep 28; cited 2016 Feb 17]. Available from: https://fivethirtyeight.com/features/33-million-americans-still-dont-have-health-insurance/
- Ramsey SD, Bansal A, Fedorenko CR, et al. Financial insolvency as a risk factor for early mortality among patients with cancer (USA). J Clin Oncol. 2016;34(9):980–986.
- Huntington SF, Weiss BM, Vogl DT, et al. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Oncol. 2015;2(10):e408–e416.
- Banegas MP, Guy GP Jr, de Moor JS, et al. Cost of cancer care for working-age cancer survivors, medical debt and bankruptcy create financial hardships. Health Aff (Millwood). 2016;35(1):54–61.
- Mustacchi G, Generali D. Cost-effectiveness and sustainability of breast cancer screening and new anti-cancer drugs. J Med Econ. 2017;20(4):405–408.
- International Monetary Fund [Internet] [cited 2022 Feb 2]. Available from: https://www.imf.org/external